2013 World Congress on Huntington’s Disease, Rio De Janeiro, Brazil

1949

 

» Sunday, September 15, 2013

• Room 1 – PROFESSIONALS
Time Activity
13:00-14:30 Plenary Session 1
Patients‘ Perspective
HD in Latin America
Speaker: RODRIGO OSÓRIO (Chile)
The role of HD families in driving scientific progress
Speaker: TAÍSE CADORE (Brazil/SP)
Youth and HD
Speaker: MATTHEW ELLISON (United States)
A global perspective
Speaker: ANN JONES (Australia)
14:30-16:00 Parallel Session 1
Basic Science
What do we really know about huntington function in HD?
Speaker: ELENA CATTANEO (Italy/italy)
Molecular chaperones in HD
Speaker: TIAGO FLEMING OUTEIRO (Germany)
Is HD also a prion disease?
Speaker: MARCY E. MACDONALD (United States)
Synaptic mechanisms in Huntington’s disease – understanding the HD brain to develop novel therapeutics
Speaker: IGNACIO MUÑOZ-SANJUAN (United States)
16:00-16:30 Break
16:30-18:00 Parallel Session 3
Epidemiology
What can we do to determine the actual prevalence of HD?
Speaker: MICHAEL HAYDEN (Canada)
Prevalence of HD in Latin America
Speaker: EMILIA M GATTO (Argentina)
Prevalence of HD in Oceania/Asia
Speaker: ANDREW CHURCHYARD (Australia)
Prevalence of HD in Europe
Speaker: CATHERINE SACKLLEY (United Kingdom)
18:00-19:00 OzBuzz
19:00- Opening Ceremony followed by Welcome Function
• Room 2 – PATIENTS
Time Activity
14:30-16:00 Parallel Session 2
Epidemiology
What can we do to determine the actual prevalence of HD?
Speaker: MICHAEL HAYDEN (Canada)
Prevalence of HD in Latin America
Speaker: EMILIA M GATTO (Argentina)
Prevalence of HD in Oceania/Asia
Speaker: ANDREW CHURCHYARD (Australia)
Prevalence of HD in Europe
Speaker: CATHERINE SACKLLEY (United Kingdom)
16:00-16:30 Break
16:30-18:00 Parallel Session 4
Basic Science
What do we really know about huntington function in HD?
Speaker: ELENA CATTANEO (Italy/italy)
Molecular chaperones in HD
Speaker: TIAGO FLEMING OUTEIRO (Germany)
Is HD also a prion disease?
Speaker: MARCY E. MACDONALD (United States)
Synaptic mechanisms in Huntington’s disease – understanding the HD brain to develop novel therapeutics
Speaker: IGNACIO MUÑOZ-SANJUAN (United States)

 

» Monday, September 16, 2013

• Room 1 – PROFESSIONALS
Time Activity
08:00-09:30 Plenary Session 2
Premanifest HD
Premanifest or subtly manifest HD?
Speaker: SARAH TABRIZI (United Kingdom)
PREDICT-HD and TRACK-HD: A Critical View
Speaker: KARL KIEBURTZ (United States)
Discussion
09:30-11:00 Parallel Session 5
Premanifest HD
Motor findings in premanifest HD
Oculomotor abnormalities in premanifest HD
Speaker: TRAVIS H TURNER (United States)
Neuropsychology in premanifest HD
Speaker: JULIE STOUT (Australia)
MRI biomarkers in premanifest HD
Speaker: RACHAEL SCAHILL (United Kingdom)
11:00-11:30 Break
11:30-13:00 Poster Session 1
13:00-14:00 Lunch Break
14:00-15:30 Plenary Session 3
Coping
Suicidality in Huntington‘s disease
Speaker: AAM HUBERS (Netherlands)
Impact of HD in families
Speaker: LOUISE VETTER (United States)
Gene Veritas
Speaker: KENNETH SERBIN (United States)
Living with HD
15:30-16:00 Break
16:00-17:30 Parallel Session 7
Clinical Features
A view of HD in Maracaibo
Speaker: ROBERTO WEISER (Venezuela, RB)
Juvenile HD
Speaker: MARTHA NANCE (United States)
Motor assessment reviewed
Speaker: RALF REILMANN (Germany)
Is there evidence for geographic variability of the clinical expression of HD?
Speaker: CARLO COSENTINO (Peru)
Differential Diagnosis of HD
Speaker: FRANCISCO CARDOSO (Brazil/MG)
17:30-18:30 OzBuzz
• Room 2 – PATIENTS
Time Activity
09:30-11:00 Parallel Session 6
Clinical Features
A view of HD in Maracaibo
Speaker: ROBERTO WEISER (Venezuela, RB)
Juvenile HD
Speaker: MARTHA NANCE (United States)
Motor assessment reviewed
Speaker: RALF REILMANN (Germany)
Is there evidence for geographic variability of the clinical expression of HD?
Speaker: CARLO COSENTINO (Peru)
Differential Diagnosis of HD
Speaker: FRANCISCO CARDOSO (Brazil/MG)
11:00-11:30 Break
11:30-13:00 IHA/ABH Session 1
13:00-14:00 Lunch Break
16:00-17:30 Parallel Session 8
Premanifest HD
Premanifest or subtly manifest HD?
Speaker: SARAH TABRIZI (United Kingdom)
MRI biomarkers in premanifest HD
Speaker: RACHAEL SCAHILL (United Kingdom)
Neuropsychology in premanifest HD
Speaker: JULIE STOUT (Australia)
Motor findings in premanifest HD
Oculomotor abnormalities in premanifest HD
Speaker: TRAVIS H TURNER (United States)

 

» Tuesday, September 17, 2013

• Room 1 – PROFESSIONALS
Time Activity
08:00-09:30 Plenary Session 4
Genetics
Modifiers of the HD gene
Speaker: JIM GUSELLA (United States)
What animal models tell us about HD genetics
Speaker: LESLEY JONES (United Kingdom)
Genetic aspects of HD in Latin America
Speaker: LAURA JARDIM (Brazil/RS)
Genetic discrimination in HD –
Speaker: JANE S PAULSEN (United States)
09:30-11:00 Parallel Session 9
Biological Markers
Imaging
Neurophysiology
Speaker: MICHAEL ORTH (Germany)
Spinal Fluid
Biomarkers and Outcomes in HD
Speaker: CRISTINA SAMPAIO (United States)
11:00-11:30 Break
11:30-13:00 Poster Session 2
13:00-14:00 Lunch Break
14:00-15:30 Plenary Session 5
Genetic Testing
Current Guidelines
Speaker: RHONA MACLEOD (United Kingdom)
Panel of discussion
RHONA MACLEOD (United Kingdom)
FREDERICO MICHELI (Argentina)
ASUNCIÓN MARTINEZ (Spain)
MARK GUTTMAN (Canada)
AAD TIBBEN (Netherlands)
LOUISE VETTER (United States)
15:30-16:00 Break
16:00-17:30 Plenary Session 6
Enroll HD Session at the WCHD in Rio
An Update on Enroll-HD: Current status and future plans
Speaker: JOE GIULIANO (United States)
Haplotyping of HD Clusters in Latin America: An Enroll-HD Sub-Study
Speaker: CLAUDIA PERANDONES (Argentina)
Plans for Data Sharing and Use in Enroll-HD
Speaker: SARAH CAMARGOS (Brazil/MG)
Plans for Data Sharing and Use in Enroll-HD
Speaker: MONICA HADDAD (Brazil/SP)
17:30-18:30 OzBuzz
18:30-19:30 Dingdingdong
• Room 2 – PATIENTS
Time Activity
09:30-11:00 IHA/ABH Session 2
11:00-11:30 Break
11:30-13:00 Parallel Session 10
Genetics
Modifiers of the HD gene
Speaker: JIM GUSELLA (United States)
What animal models tell us about HD genetics
Speaker: LESLEY JONES (United Kingdom)
Genetic aspects of HD in Latin America
Speaker: LAURA JARDIM (Brazil/RS)
Genetic discrimination in HD
Speaker: JANE S PAULSEN (United States)

 

» Wednesday, September 18, 2013

• Room 1 – PROFESSIONALS
Time Activity
08:00-12:00 Plenary Session 7
Therapy
Update of clinical trials in HD. Is there reason for hope?
Speaker: Bernhard Landwehrmeyer (Germany)
An evidence-based approach in the treatment of HD
Speaker: JOAQUIM FERREIRA (Portugal)
RNAi-based therapies for HD
Speaker: NEIL ARONIN (United States)
Modulation of huntingtin levels as a therapeutic approach for HD
Speaker: DOUGLAS MACDONALD (United States)
Management of behavioural problems in HD
Speaker: DAVID CRAUFURD (United Kingdom)
Late stage treatment options and wishes in relation to quality of life
Speaker: RAYMUND ROOS (Netherlands)
Basic care
Speaker: DANIELA RAE (United Kingdom)
Cellular therapy
DBS and HD
Swallowing and Nutrition
Speaker: FRANCIS O WALKER (United States)
Discussion
12:00- Meeting Close – End of 2013 WCHD

 

READ MORE

Print Friendly, PDF & Email